IVABRADINE NHPL ivabradine (as hydrochloride) 7.5 mg tablet blister pack

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

العنصر النشط:

ivabradine hydrochloride, Quantity: 8.085 mg (Equivalent: ivabradine, Qty 7.5 mg)

متاح من:

Arrotex Pharmaceuticals Pty Ltd

الشكل الصيدلاني:

Tablet, film coated

تركيب:

Excipient Ingredients: lactose monohydrate; magnesium stearate; maize starch; maltodextrin; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; iron oxide red; macrogol 4000

طريقة التعاطي:

Oral

الوحدات في الحزمة:

56, 14

نوع الوصفة الطبية :

(S4) Prescription Only Medicine

الخصائص العلاجية:

Treatment of chronic stable angina Symptomatic treatment of chronic stable angina due to atherosclerotic coronary artery disease in patients with normal sinus rhythm and heart rate at or above 70 bpm, who are unable to tolerate or have a contraindication to the use of beta-blockers.,Treatment of chronic heart failure Treatment of symptomatic chronic heart failure of NYHA Classes II or III and with documented left ventricular ejection fraction (LVEF) ? 35% in adult patients in sinus rhythm and with heart rate at or above 77 bpm, in combination with optimal standard chronic heart failure treatment.

ملخص المنتج:

Visual Identification: Ivabradine 7.5 mg is light salmon, round (7 mm diameter), biconvex film-coated tablet.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

الوضع إذن:

Registered

تاريخ الترخيص:

2018-01-11